Publication date: Jun 01, 2023
Coronavirus disease 2019 (COVID-19) has multiple impacts on the human body. The immunological effect is one of the prominent ones, which is thought to be fundamental in many physical manifestations and disease severity. Herpes zoster (HZ) reactivation has been well-linked to immunity; immunocompromised states predispose a person to HZ. Studies have raised concerns about HZ incidences in COVID-19 patients; however, the clinical characteristics of the HZ cases among patients with and without COVID-19 are another area to be explored. In this retrospective analysis, we compared the clinical and demographic characteristics of HZ cases presented to our outpatient department immediately before and during the early second wave of the COVID-19 pandemic (September 2020 to April 2021) in India. The cases were divided into two groups based on the history of COVID-19 infections. The clinico-demographic characteristics were then compared using an unpaired t-test, Fisher’s exact test, and analysis of variance as applicable using InStat software; a two-sided p-value
| Concepts | Keywords |
|---|---|
| Coronavirus | clinical characteristics |
| Outpatient | covid-2019 |
| September | herpes zoster reactivation |
| Software | hospital epidemiology |
| varicella-zoster |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Herpes Zoster |
| disease | MESH | COVID-19 |
| disease | MESH | Infection |
| disease | IDO | history |
| disease | MESH | varicella |